Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB

Li-Juan Jiang; Song-Bin Guo; Zhao-Hui Zhou; Zhi-Yong Li; Fang-Jian Zhou; Chun-Ping Yu; Mei Li; Wei-Juan Huang; Zhuo-Wei Liu; Xiao-Peng Tian

doi:10.1002/ctm2.1555

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1555 DOI: 10.1002/ctm2.1555

LETTER TO THE JOURNAL

Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB

Li-Juan Jiang ¹^,²
, Song-Bin Guo ¹^,³
, Zhao-Hui Zhou ¹^,²
, Zhi-Yong Li ¹^,²
, Fang-Jian Zhou ¹^,²
, Chun-Ping Yu ¹^,²
, Mei Li ¹^,⁴
, Wei-Juan Huang ⁵^,⁶
, Zhuo-Wei Liu ¹^,²
, Xiao-Peng Tian ¹^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Li-Juan Jiang, Song-Bin Guo, Zhao-Hui Zhou, Zhi-Yong Li, Fang-Jian Zhou, Chun-Ping Yu, Mei Li, Wei-Juan Huang, Zhuo-Wei Liu, Xiao-Peng Tian. Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB. Clinical and Translational Medicine, 2024, 14(1): e1555 DOI:10.1002/ctm2.1555

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians. 2021;71:209-249.

[2]	Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895-1904.

[3]	Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341-352.

[4]	Lang B, Armaos A, Tartaglia GG. RNAct: protein–RNA interaction predictions for model organisms with supporting experimental data. Nucleic Acids Res. 2019;47:D601-D606.

[5]	Tang Z-Z, Sliwoski GR, Chen G, et al. PSCAN: spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection. Genome Biol. 2020;21:217.

[6]	Zhou W, Gross KM, Kuperwasser C. Molecular regulation of Snai2 in development and disease. J Cell Sci. 2019;132:jcs235127.

[7]	He D, Gao J, Zheng L, et al. TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway. Int J Oncol. 2021;59:84.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.